Css LLC Summit Therapeutics Inc. Put Options Transaction History

Css LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$1.54 - $2.42 $2,464 - $3,872	-1,600 Reduced 28.57%	4,000 $7,000
Q2 2023 Aug 14, 2023	SELL	$1.32 - $2.81 $33,000 - $70,250	-25,000 Reduced 81.7%	5,600 $14,000
Q1 2023 May 15, 2023	BUY	$1.38 - $5.41 $42,228 - $165,546	30,600 New	30,600 $53,000

107

41.3M

103K

29.9K

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $1.46B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.